$0.0330
-0.00700-17.50%
At close: -
$0.0405
0.0075022.73%
After Hours: 8:00 AM EDT
Comments
Loading...
Latest Syros Pharmaceuticals Stock News | OTC:SYRS | Benzinga
Get the latest news on Syros Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Syros Pharmaceuticals performance
Categories: All
Tuesday, March 18, 2025
Friday, March 14, 2025
Wednesday, March 12, 2025
Tuesday, March 11, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Tuesday, November 19, 2024
Monday, November 18, 2024
Wednesday, November 13, 2024
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results
- Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings
- Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
- US Stocks Mixed; Inflation Rate Increases In October
- Syros Pharmaceuticals shares are trading lowe...
- TD Cowen Downgrades Syros Pharmaceuticals to ...
- HC Wainwright & Co. Downgrades Syros Pharmace...
- JMP Securities Downgrades Syros Pharmaceutica...
- Brookline Capital Downgrades Syros Pharmaceut...
- Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Tuesday, November 12, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Tuesday, August 13, 2024
- Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
- S&P 500 Gains 1%; Home Depot Earnings Top Views
- Piper Sandler Reiterates Overweight on Syros ...
- Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
- Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
- JMP Securities Maintains Market Outperform on...
- HC Wainwright & Co. Maintains Buy on Syros Ph...
- Syros Pharmaceuticals shares are trading lowe...
- Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket